BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9766563)

  • 1. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas.
    Waha A; Sturne C; Kessler A; Koch A; Kreyer E; Fimmers R; Wiestler OD; von Deimling A; Krebs D; Schmutzler RK
    Int J Cancer; 1998 Oct; 78(3):306-9. PubMed ID: 9766563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines.
    Kovalev S; Mateen A; Zaika AI; O'Hea BJ; Moll UM
    Int J Oncol; 2000 Apr; 16(4):825-31. PubMed ID: 10717253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
    Laake K; Odegård A; Andersen TI; Bukholm IK; Kåresen R; Nesland JM; Ottestad L; Shiloh Y; Børresen-Dale AL
    Genes Chromosomes Cancer; 1997 Mar; 18(3):175-80. PubMed ID: 9071570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM mutations in cancer families.
    Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
    Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
    Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
    Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
    Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
    Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.
    Angèle S; Treilleux I; Tanière P; Martel-Planche G; Vuillaume M; Bailly C; Brémond A; Montesano R; Hall J
    Clin Cancer Res; 2000 Sep; 6(9):3536-44. PubMed ID: 10999741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
    Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
    Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the ATM gene in breast cancer.
    Lu Y; Condie A; Bennett JD; Fry MJ; Yuille MR; Shipley J
    Cancer Genet Cytogenet; 2001 Apr; 126(2):97-101. PubMed ID: 11376801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.
    Ye C; Cai Q; Dai Q; Shu XO; Shin A; Gao YT; Zheng W
    Cancer; 2007 May; 109(9):1729-35. PubMed ID: 17366603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
    Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
    Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
    Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
    Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.
    Vo QN; Kim WJ; Cvitanovic L; Boudreau DA; Ginzinger DG; Brown KD
    Oncogene; 2004 Dec; 23(58):9432-7. PubMed ID: 15516988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What do we know about ATM protein expression in breast tissue?].
    Angèle S; Tanière P; Hall J
    Bull Cancer; 2001 Jul; 88(7):671-5. PubMed ID: 11495820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM protein synthesis patterns in sporadic breast cancer.
    Kairouz R; Clarke RA; Marr PJ; Watters D; Lavin MF; Kearsley JH; Lee CS
    Mol Pathol; 1999 Oct; 52(5):252-6. PubMed ID: 10748873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM mutations in B-cell chronic lymphocytic leukemia.
    Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
    Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia.
    Takeuchi S; Koike M; Park S; Seriu T; Bartram CR; Taub HE; Williamson IK; Grewal J; Taguchi H; Koeffler HP
    Br J Haematol; 1998 Nov; 103(2):536-8. PubMed ID: 9827931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.